BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Robert Walters China Salary Survey 2023: Easing of Epidemic Control: Recruitment Market Stabilises, Data Security and Compliance Talent being Key Recruitment Targets

The demand for mid-to-senior professionals with specific technical skills and background is increasing, such as new energy, integrated circuits, medical de...

March 02, 2023 | Analysis

JW Therapeutics Announces Initiation of Clinical Study of JWATM214 in Patients with Advanced Hepatocellular Carcinoma

Primary hepatic cancer is a common malignant tumor of the digestive system worldwide, with high malignancy and hepatic prognosis. As the most common pathol...

March 01, 2023 | News

Everest Medicines Commences Operations at State-of-the-Art mRNA Vaccine Facility.

Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercializa...

February 28, 2023 | News

Porton Advanced and Yinjia Biosciences Partner to Enhance CDMO Technology Platform

Porton Advanced CDMO offers end-to-end gene and cell therapy services covering plasmids, cell therapy, gene therapy, oncolytic virus, mRNA therapy, and bac...

February 27, 2023 | News

Medtec China 2023 will be held on June 1-3, 2023, in Suzhou China

Meanwhile, the most recent COVID-19 prevention and control optimization policies have made it easier for overseas enterprises to participate in trade fairs...

February 27, 2023 | News

Keymed and Lepu Biopharma gain global exclusive license for CMG901 from AstraZeneca.

CMG901 is currently in a Phase I clinical trial for the treatment of Claudin 18.2-positive solid tumors. Preliminary results from the Phase 1 trial indicat...

February 24, 2023 | News

Zhongchao Inc. Renews Partnership with Johnson & Johnson (China)

The renewed partnership is expected to further strengthen two parities' cooperation in the global advanced field of innovative medical and health. As the ...

February 24, 2023 | News

Fapon Biopharma's Anti-CD47 Antibody FP002 Earns IND Approval from FDA

FP002 is a humanized anti-CD47 IgG4 monoclonal antibody, developed and patented by Fapon Biopharma. It binds strongly to the CD47 protein on the surface of...

February 23, 2023 | News

AnPac Bio Announces Positive Results from its Multi-Year and Multi-Cancer Test Follow-Up Study

To date, the study has enrolled over 18,000 individuals from a general population of 230,000 persons located in China. The test subjects were tested ...

February 23, 2023 | News

Neurophth completes Phase III trial enrollment for LHON gene therapy

Neurophth Therapeutics, Inc. ("Neurophth") announced today that the last patient has been enrolled in the Phase III clinical trial for the treatment o...

February 22, 2023 | News

Duoning Enters Partnership with BioAces to Expand Cell Analysis Portfolio

Duoning obtained exclusive license from BioAces for its cell analysis portfolio Through the partnership, the two companies will advance the development ...

February 21, 2023 | News

Clover Enters into Exclusive Agreement to Commercialize Quadrivalent Seasonal Influenza Vaccine in Mainland China

-- Clover to leverage its established and growing commercial infrastructure to exclusively distribute Adimmune’s AdimFlu-S (QIS), the only imported q...

February 20, 2023 | News

Boan Biotech's Investigational Long-acting Anti-IL-4Rα Antibody BA2101 Administered for First Patient in Phase I Clinical Trial

BA2101 is the first long-acting anti-IL-4Rα monoclonal antibody that enters the clinical trial stage in the country. It is intended to be used for tr...

February 16, 2023 | News

BioDuro-Sundia Expands Drug Discovery Capacity and Capability

Dr. Xiang Li, President of BioDuro-Sundia Drug Discovery, explains: “At BioDuro-Sundia, we are fully invested in our clientele and pro-actively plann...

February 15, 2023 | News

Stay Connected